TRNS
TRANSCAT INC (TRNS
NASDAQ · Industrials · Industrial - Distribution · US
$86.00
+0.84%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$85.40
From 52W high−12.03%
Volume117664.00
Market cap$804.94M
P/E (TTM)232.4x
P/S (TTM)2.3x
Div yield—
Key dataSep 18, 2026
Open
$85.40
From 52W high
−12.03%
Volume
117664.00
Market cap
$804.94M
ValuationView details →
P/E (Fwd)
43.8x
EV/EBITDA
24.2x
P/E (TTM)
232.4x
RSI (14)
43.7
MomentumView details →
1D Return
+0.84%
YTD Return
+47.21%
SummaryUpdated Jun 1, 2026
Transcat, Inc. (NASDAQ:TRNS) is a Rochester, New York-based industrial services company that was incorporated in 1964 and went public in 1977. The company has evolved from its origins into a specialized provider of calibration services and test equipment distribution, primarily serving highly regulated industries such as life sciences, aerospace, and defense. Over nearly six decades, Transcat has grown through both organic expansion and strategic acquisitions, establishing itself as a leading player in the precision measurement and calibration industry across the United States, Canada, and internationally.
Similar companies
Latest newsMore news →
Transcat, Inc. acquired Southeastern Biomedical, expanding its biomedical calibration channel.20d agoTranscat, Inc. reported quarterly earnings of $0.51 per share for the quarter ended June 2026, beating the Zacks Consensus Estimate of $0.37 per share, and compared to $0.59 per share a year earlier.47d agoTranscat Inc reported its Q1 FY2027 financial results with total consolidated revenue of $92.945 million, GAAP net income of $1.331 million, and diluted EPS of $0.14.48d ago